{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:48:36Z","timestamp":1785235716403,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.micpath.2016.08.014","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T09:47:40Z","timestamp":1471945660000},"page":"106-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["A soluble form of Siglec-9 provides a resistance against Group B Streptococcus (GBS) infection in transgenic mice"],"prefix":"10.1016","volume":"99","author":[{"given":"Mitsumasa","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinuyo","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Suyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Morimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Nishijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2016.08.014_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.spid.2006.06.007","article-title":"Issues of antimicrobial resistance in group B streptococcus in the era of intrapartum antibiotic prophylaxis","volume":"17","author":"Edwards","year":"2006","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"10.1016\/j.micpath.2016.08.014_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bpobgyn.2007.01.003","article-title":"Perinatal group B streptococcal disease","volume":"21","author":"Heath","year":"2007","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.micpath.2016.08.014_bib3","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial meningitis in the United States, 1998\u20132007","volume":"364","author":"Thigpen","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.micpath.2016.08.014_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1099\/00222615-10-1-103","article-title":"Epidemiology of group-B streptococcal carriage in pregnant women and newborn infants","volume":"10","author":"Ferrieri","year":"1977","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.micpath.2016.08.014_bib5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0002-9378(84)90534-9","article-title":"Bacterial attachment to the chorioamniotic membranes","volume":"148","author":"Galask","year":"1984","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.micpath.2016.08.014_bib6","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.1073\/pnas.84.20.7208","article-title":"Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence","volume":"84","author":"Rubens","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2016.08.014_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/infdis\/147.5.857","article-title":"Assessment of the virulence factors of group B streptococci: correlation with sialic acid content","volume":"147","author":"Shigeoka","year":"1983","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.micpath.2016.08.014_bib8","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1073\/pnas.86.22.8983","article-title":"Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule","volume":"86","author":"Wessels","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2016.08.014_bib9","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1128\/iai.60.10.3986-3993.1992","article-title":"Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci","volume":"60","author":"Marques","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2016.08.014_bib10","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/IAI.67.4.1866-1870.1999","article-title":"Capsular sialic acid limits C5a production on type III group B streptococci","volume":"67","author":"Takahashi","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2016.08.014_bib11","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/JCM.00117-07","article-title":"Serotype IX, a proposed new Streptococcus agalactiae serotype","volume":"45","author":"Slotved","year":"2007","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.micpath.2016.08.014_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nri3737","article-title":"Siglec regulation of immune cell function in disease","volume":"14","author":"Macauley","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2016.08.014_bib13","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood-2008-11-187302","article-title":"Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response","volume":"113","author":"Carlin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2016.08.014_bib14","doi-asserted-by":"crossref","first-page":"e1003846","DOI":"10.1371\/journal.ppat.1003846","article-title":"Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in\u00a0vivo","volume":"10","author":"Chang","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2016.08.014_bib15","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.299.17.2056","article-title":"Epidemiology of invasive group B streptococcal disease in the United States, 1999\u20132005","volume":"299","author":"Phares","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2016.08.014_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bmj.323.7312.533","article-title":"Meningitis in infancy in England and Wales: follow up at age 5 years","volume":"323","author":"Bedford","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.micpath.2016.08.014_bib17","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/JB.01155-06","article-title":"Group B streptococcal capsular sialic acids interact with Siglecs (immunoglobulin-like lectins) on human leukocytes","volume":"189","author":"Carlin","year":"2007","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.micpath.2016.08.014_bib18","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbrc.2014.06.009","article-title":"A\u00a0soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice","volume":"450","author":"Tomioka","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2016.08.014_bib19","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.4049\/jimmunol.173.11.6841","article-title":"The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells","volume":"173","author":"Avril","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.micpath.2016.08.014_bib20","doi-asserted-by":"crossref","first-page":"43117","DOI":"10.1074\/jbc.M403538200","article-title":"Negative regulation of T cell receptor signaling by Siglec-7 (p70\/AIRM) and Siglec-9","volume":"279","author":"Ikehara","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.micpath.2016.08.014_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"key":"10.1016\/j.micpath.2016.08.014_bib22","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2016.08.014_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1348-0421.2001.tb01314.x","article-title":"Delayed onset of systemic bacterial dissemination and subsequent death in mice injected intramuscularly with Streptococcus pyogenes strains","volume":"45","author":"Saito","year":"2001","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2016.08.014_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1749-6632.2003.tb07408.x","article-title":"Mechanisms of humoral immunity during Ehrlichia chaffeensis infection","volume":"990","author":"Winslow","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.micpath.2016.08.014_bib25","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.4049\/jimmunol.1200356","article-title":"Crosstalk between human IgG isotypes and murine effector cells","volume":"189","author":"Overdijk","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.micpath.2016.08.014_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-3083.1989.tb01225.x","article-title":"The IgG subclass pattern of complement activation depends on epitope density and antibody and complement concentration","volume":"30","author":"Garred","year":"1989","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.micpath.2016.08.014_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/eji.1830210103","article-title":"Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration","volume":"21","author":"Michaelsen","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2016.08.014_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1086\/376457","article-title":"Prematurity is the major risk factor for lateonset group B Streptococcus disease","volume":"188","author":"Lin","year":"2003","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.micpath.2016.08.014_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(98)07128-1","article-title":"Group B streptococcus","volume":"353","author":"Schuchat","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2016.08.014_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/2051013615579869","article-title":"Group B Streptococcus vaccine: state of the art","volume":"3","author":"Nuccitelli","year":"2015","journal-title":"Ther. Adv. Vaccines"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401016301590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401016301590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T15:33:43Z","timestamp":1656776023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401016301590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":30,"alternative-id":["S0882401016301590"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2016.08.014","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A soluble form of Siglec-9 provides a resistance against Group B Streptococcus (GBS) infection in transgenic mice","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2016.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}